Literature DB >> 35531654

The contribution of the immune system to genitourinary fibrosis.

Karen M Doersch1, Daniel Barnett2, Abbie Chase1, Daniel Johnston1, J Scott Gabrielsen1.   

Abstract

Fibrotic diseases of the genitourinary tract are devastating and incompletely understood pathologies. These diseases include urethral and ureteral strictures, retroperitoneal fibrosis, and Peyronie's disease. They can contribute to obstructive uropathy and sexual dysfunction. Poor understanding of the pathophysiology of these diseases severely limits our ability to prevent and treat them. Genitourinary fibrotic diseases likely represent related pathologies that share common underlying mechanisms involving wound healing in response to injury. These diseases share the common feature of extracellular matrix abnormalities-such as collagen deposition, transforming growth factor-β accumulation, and dysregulation of collagen maturation-leading to abnormal tissue stiffness. Given the association of many of these diseases with autoimmunity, a systemic pro-inflammatory state likely contributes to their associated fibrogenesis. Herein, we explore the immunologic contribution to fibrogenesis in several fibrotic diseases of the genitourinary system. Better understanding how the immune system contributes to fibrosis in these diseases may improve prevention and therapeutic strategies and elucidate the functions of immunologic contributors to fibrosis in general.

Entities:  

Keywords:  Genitourinary fibrosis; Peyronie’s disease; inflammation; retroperitoneal fibrosis; ureteral stricture; urethral stricture

Mesh:

Substances:

Year:  2022        PMID: 35531654      PMCID: PMC9134766          DOI: 10.1177/15353702221090872

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  134 in total

1.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Mechanisms by which fibrin and fibronectin appear in healing wounds: implications for Peyronie's disease.

Authors:  L Van de Water
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

3.  Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series.

Authors:  Paul J Scheel; Nancy Feeley; Stephen M Sozio
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

4.  AMPK Activation Regulates LTBP4-Dependent TGF-β1 Secretion by Pro-inflammatory Macrophages and Controls Fibrosis in Duchenne Muscular Dystrophy.

Authors:  Gaëtan Juban; Marielle Saclier; Houda Yacoub-Youssef; Amel Kernou; Ludovic Arnold; Camille Boisson; Sabrina Ben Larbi; Mélanie Magnan; Sylvain Cuvellier; Marine Théret; Basil J Petrof; Isabelle Desguerre; Julien Gondin; Rémi Mounier; Bénédicte Chazaud
Journal:  Cell Rep       Date:  2018-11-20       Impact factor: 9.423

Review 5.  Idiopathic Retroperitoneal Fibrosis.

Authors:  Augusto Vaglio; Federica Maritati
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

6.  The genetic and bacteriological aspects of Peyronie's disease.

Authors:  D J Ralph; G Schwartz; W Moore; J P Pryor; A Ebringer; G F Bottazzo
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

7.  Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.

Authors:  Paul J Scheel; Jonathan Piccini; M Hafizur Rahman; Leo Lawler; Thomas Jarrett
Journal:  J Urol       Date:  2007-05-17       Impact factor: 7.450

Review 8.  Male urethral strictures and their management.

Authors:  Lindsay A Hampson; Jack W McAninch; Benjamin N Breyer
Journal:  Nat Rev Urol       Date:  2013-12-17       Impact factor: 14.432

9.  Significant alterations of serum cytokine levels in patients with Peyronie's disease.

Authors:  Reinhold P Zimmermann; Gerhard Feil; Conny Bock; Lorenz Hoeltl; Arnulf Stenzl
Journal:  Int Braz J Urol       Date:  2008 Jul-Aug       Impact factor: 1.541

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.